Daily RSI is in an attempt of moving above 60 levelsand volume has started to expand during upmove.

Syngene International Ltd. key Products/Revenue Segments include Contract Research & Contract Manufacturing (CRAMS), Other Operating Revenue and Scrap for the year ending 31-Mar-2022.

Brokerage CLSA maintained a buy rating on Syngene International while Motilal Oswal initiated coverage on Home First Finance with a buy call. Furthermore, Sharekhan initiated a buy on Devyani International.

The scrip of Syngene International has settled 2.38 per cent lower at Rs 565 apiece on the BSE.ICICI Prudential Mutual Fund was among the entities that lapped up the company's shares.As of June year, of the promoters' holding of 70.29 per cent, Biocon held a 69.99 per cent stake in Syngene, the shareholding pattern with the exchange showed

“ Syngene has signed a 10-year strategic deal with Zoetis in animal health: It was a real piece of innovation from Zoetis and we are delighted to sign the deal which is a strategic one and is in the biologics manufacturing part of the organisation. They should get going with that set up starting this year and then we will start to see it in the P&L much more strongly from next year. It starts the rebalancing of the organisation.”

Wipro, Havells, IndusInd Bank, Gland Pharma, Tata Communications, Oracle Financial, Syngene International, Century Plyboards, Mastek and Ceat are among the companies that will announce their earnings for the quarter ended June 2022.

Shares of DU Digital Global and Paisalo Digital will go ex-split today. DU Digital Global had announced the splitting of shares into face value of Rs 2 from the face value of Rs 10 while Paisalo Digital had announced the splitting of shares into face value of Re 1 from the face value of Rs 10.

The brokerage believes that weakness in China's export prices will dent the company, leading to an EBITDA cut by 32-34 per cent on the back of lower realizations.

On a standalone basis, the companys quarterly net profit stood at Rs 147 crore in March 2022, down 8.41 per cent from Rs 160.50 crore in March 2021. Net sales clocked in at Rs 758.70 crore in March 2022, up 15.29 per cent from Rs 658.10 crore in March 2021, reports said.

Share your videos with friends, family, and the world

Share your videos with friends, family, and the world

Syngene International Ltd., incorporated in the year 1993, is a Mid Cap company (having a market cap of Rs 24969.62 Crore) operating in Pharmaceuticals sector.

​​A rally in the Bank Nifty found stiff resistance near its 50-day EMA. Selling pressure intensified as intraday recoveries remained short-lived, and eventually Bank Nifty settled below the 37,000 mark. Sustenance below 37,500 is expected to keep Bank Nifty under pressure.